Search Login Register
rivastigmine
(Exelon)
Summary
Also Known As:
Exelon; (S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate; ENA 713; ENA-713; SDZ ENA 713 Show All >>
Networked: 701
relevant articles (121 outcomes,
220 trials/studies)
for this Drug
Key Diseases for which rivastigmine is
Relevant
-
Alzheimer Disease (Alzheimer's Disease)
:
68 outcomes 115 studies in 438 results
-
Dementia (Dementias)
:
41 outcomes 58 studies in 226 results
-
Parkinson Disease (Parkinson's Disease)
:
13 outcomes 17 studies in 72 results
-
Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
:
6 outcomes 11 studies in 23 results
-
Schizophrenia (Dementia Praecox)
:
4 outcomes 10 studies in 17 results
Show All >>
Drugs Related to rivastigmine
-
donepezil (Aricept)
-
Galantamine (Galanthamine)
-
Cholinesterase Inhibitors (Anticholinesterases)
-
Memantine (Namenda)
-
Cholinesterases (Cholinesterase)
-
rivastigmine (Exelon)
-
Tacrine (Cognex)
-
Trichlorfon (Metrifonate)
-
Ginkgo biloba extract 761 (Rokan)
-
Acetylcholinesterase
Show All >>
Therapies Related to rivastigmine
-
Transdermal Patch
-
Activities of Daily Living (ADL)
-
Home Nursing (Nursing, Home)
-
Cutaneous Administration
-
Drug Therapy (Chemotherapy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.